Name: Human Microbiome Drug Targets: Modern Approaches in Disease Management (en Inglés)
Price: 630008.00 COP
Availability: InStock
Author: Dable-Tupas Genevieve,Karunakaran Rohini,C. Lim Peter Paul
ISBN: 9780443154355

portada Human Microbiome Drug Targets: Modern Approaches in Disease Management (en Inglés)

Human Microbiome Drug Targets: Modern Approaches in Disease Management (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Dable-Tupas Genevieve,Karunakaran Rohini,C. Lim Peter Paul

Idioma

Inglés

N° páginas

290

Encuadernación

Tapa Blanda

ISBN13

9780443154355

N° edición

Human Microbiome Drug Targets: Modern Approaches in Disease Management (en Inglés)

Dable-Tupas Genevieve,Karunakaran Rohini,C. Lim Peter Paul (Autor) · Elsevier · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 21 días háb.

$ 1.260.015$ 630.008

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 630.008

¡Envío Gratis! Llega entre el 31 Ago y el 07 Sep a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Human Microbiome Drug Targets: Modern Approaches in Disease Management (en Inglés)"

Human Microbiome Drug Targets: Modern Approaches in Disease Management presents fundamental information on the human microbiome, looking into the relationship between the microbiome and how it changes with specific diseases. Delving into the multifaceted roles of the microbiome in health and disease, the book's chapters discuss the role of the human microbiome in the pathophysiologic understanding of relevant diseases or disorders and their management. As changes in the human microbiome can provide clues to the probable cause and effect of diseases or disorders, as well as the impacts of therapy or intervention, this book is a welcomed addition to the existing research. Explaining how a better understanding of the microbiome and its impact on health and disease can pave the way for future discoveries leading to better health outcomes, this book will be of interest to drug developers, medicinal chemists, microbiologists, infectious disease specialists, biochemists, and students.